Home | MyCME | All CME | Blog | Psychlopedia

Online CME Activities

+Journal CME Activities [Series Home Page]

Gotlib et al

Journal CME

Guideline Adherence for Mentally Ill Reproductive-Aged Women on Treatment With Valproic Acid: A Retrospective Chart Review

Dorothy Gotlib, Elizabeth Perelstein, Jacob Kurlander, Kara Zivin, Michelle Riba, and Maria Muzik

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2018 | Keyword: bipolar disorder

Treating reproductive-aged female patients with valproic acid comes with serious teratogenic risks. Read this journal CME article to explore data on safety and clinical strategies.

Mota et al

Journal CME

Late-Life Exacerbation of PTSD Symptoms in US Veterans: Results From the National Health and Resilience in Veterans Study

Natalie Mota, Jack Tsai, Paul D. Kirwin, Ilan Harpaz-Rotem, John H. Krystal, Steven M. Southwick, and Robert H. Pietrzak

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2018 | Keyword: PTSD

Do you see patients who are older military veterans? Did you know that some experience exacerbated posttraumatic stress disorder (PTSD) symptoms, possibly decades after their trauma? Read this journal CME activity to find out about the prevalence and determinants of PTSD exacerbations in older age.

Simon et al

Journal CME

Risk of Suicide Attempt and Suicide Death Following Completion of the Patient Health Questionnaire Depression Module in Community Practice

Gregory E. Simon, Karen J. Coleman, Rebecca C. Rossom, Arne Beck, Malia Oliver, Eric Johnson, Ursula Whiteside, Belinda Operskalski, Robert B. Penfold, Susan M. Shortreed, and Carolyn Rutter

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2018 | Keyword: depression

When your patients complete the Patient Health Questionnaire, they are asked about the frequency of suicidal thoughts. For patients who indicate suicidal ideation, how long does their suicide risk last? How does clinical intervention change the risk? To learn more, read this journal CME study.

Lee et al

Journal CME

Antidepressant Treatment and Risk of Dementia: A Population-Based, Retrospective Case-Control Study

Cynthia Wei-Sheng Lee, Cheng-Li Lin, Fung-Chang Sung, Ji-An Liang, and Chia-Hung Kao

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2018 | Keywords: depression, dementia

Previous studies have demonstrated that depression may be a risk factor for dementia. Does the risk of dementia change when people take antidepressants? Learn more about research findings in this journal CME study, which compared the histories of antidepressant use in patients with and without dementia.

Baer et al

Journal CME

Prevalence and Impact of Obsessive-Compulsive Symptoms in Depression: A STAR*D Report

Lee Baer, Madhukar H. Trivedi, Ilana Huz, A. John Rush, Stephen R. Wisniewski, and Maurizio Fava

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keywords: depression, obsessive-compulsive disorder

When you treat patients for major depressive disorder, do you screen them for obsessive-compulsive symptoms? Read this journal CME activity based on STAR*D data to learn more about how obsessions and compulsions affect depression remission and how you can identify them.

Thomas Roth (Chair) et al

Journal CME

Managing Excessive Daytime Sleepiness

Thomas Roth, PhD (Chair), and Russell P. Rosenberg, PhD

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2017 | Keywords: narcolepsy, sleep disorders

Your patients' safety may be at risk if they have unrecognized excessive daytime sleepiness (EDS). Read this Commentary to learn how to assess EDS, to recognize any underlying conditions, and to select appropriate behavioral and pharmacologic strategies to treat both EDS and associated conditions.

Olfson et al

Journal CME

Antipsychotic Treatment of Adults in the United States

Mark Olfson, Marissa King, and Michael Schoenbaum

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: dementia, depression

When you prescribe antipsychotic agents, do you record a diagnosis of mental illness? Do you prescribe them long-term for patients with dementia? Read this journal CME activity to find out about prescription trends.

Wilkinson et al

Journal CME

Marijuana Use Is Associated With Worse Outcomes in Symptom Severity and Violent Behavior in Patients With Posttraumatic Stress Disorder

Samuel T. Wilkinson, Elina Stefanovics, Robert A. Rosenheck

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2017 | Keyword: PTSD

Despite the lack of randomized controlled trials of marijuana in the treatment of PTSD, some US states have legalized this treatment strategy. Review this journal CME article to find out more about potential outcomes of this treatment.

Sullivan et al

Journal CME

Influence of Schizophrenia Diagnosis on Providers’ Practice Decisions

Greer Sullivan, Dinesh Mittal, Christina M. Reaves, Tiffany F. Haynes, Xiaotong Han, Snigdha Mukherjee, Scott Morris, Laura Marsh, and Patrick W. Corrigan

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: schizophrenia, medical conditions

Do clinicians resemble the general public in terms of negatively viewing persons with mental illness? Read this journal CME activity to learn whether a diagnosis of schizophrenia in a case vignette influences providers’ clinical expectations and referral practices. Then, examine whether your own perspectives on the abilities and competence of high-functioning patients with schizophrenia are more negative than warranted.

Hoertel et al

Journal CME

Childhood Maltreatment and Risk of Suicide Attempt: A Nationally Representative Study

Nicolas Hoertel, Silvia Franco, Melanie M. Wall, Maria A. Oquendo, Shuai Wang, Frédéric Limosin, and Carlos Blanco

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2017 | Keywords: personality disorders, depression, anxiety, substance use disorders

Which types of childhood maltreatment are associated with greater risk of suicide attempt in adulthood? Are child abuse or neglect associated with an earlier age at first suicide attempt? Do psychopathology and sociodemographic characteristics affect the association between childhood maltreatment and suicide attempt? Explore answers to these questions in this CME journal article.

Faedda et al

Journal CME

Precursors of Bipolar Disorders: A Systematic Literature Review of Prospective Studies

Gianni L. Faedda, Ciro Marangoni, Giulia Serra, Paola Salvatore, Gabriele Sani, Gustavo H. Vázquez, Leonardo Tondo, Paolo Girardi, Ross J. Baldessarini, and Athanasios Koukopoulos

Activity | Posttest | Credits: 1.00 | Expires: 5/31/2017 | Keyword: bipolar disorder

Do you know which signs and symptoms have been identified as precursors of bipolar disorder? Read this CME journal article to learn about precursors that may arise years before syndromal onset, often with significant morbidity and disability.

Han et al

Journal CME

Prevalence and Correlates of Past 12-Month Suicide Attempt Among Adults With Past-Year Suicidal Ideation in the United States

Beth Han, Wilson M. Compton, Joseph Gfroerer, and Richard McKeon

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2017 | Keywords: mental illness, depression, substance use disorders

While not everyone with suicidal ideation progresses to a plan and an attempt, does everyone who attempts suicide first make a plan? Does the absence of a major depressive episode imply the absence of risk for a suicide attempt? How does substance use affect risk? To learn more, read this CME journal article describing results from a Substance Abuse and Mental Health Services Administration survey.

Goldstein et al

Journal CME

Excessive and Premature New-Onset Cardiovascular Disease Among Adults With Bipolar Disorder in the United States NESARC Cohort

Benjamin I. Goldstein, Ayal Schaffer, Shuai Wang, and Carlos Blanco

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2017 | Keywords: bipolar depression, depression, medical conditions

Do you integrate cardiovascular health into the assessment, monitoring, and treatment of people with bipolar disorder? Read this CME activity to learn about the risk for new-onset cardiovascular disease among patients with bipolar disorder compared with those with major depression and controls. The findings of this 3-year study, which controlled for age and risk factors such as smoking, obesity, and hypertension, may surprise you.

Frankland et al

Journal CME

Comparing the Phenomenology of Depressive Episodes in Bipolar I and II Disorder and Major Depressive Disorder Within Bipolar Disorder Pedigrees

Andrew Frankland, Ester Cerrillo, Dusan Hadzi-Pavlovic, Gloria Roberts, Adam Wright, Colleen K. Loo, Michael Breakspear, and Philip B. Mitchell

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2017 | Keywords: bipolar depression, depression

How often do you diagnose patients with major depressive disorder only to later realize they have bipolar disorder? Using a method called the Probabilistic Approach to Bipolar Depression may help you with this challenging differential diagnosis. Read this CME journal article about identifying differences in depressive presentations between bipolar disorder and MDD.

Wisco et al

Journal CME

Posttraumatic Stress Disorder in the US Veteran Population: Results From the National Health and Resilience in Veterans Study

Blair E. Wisco, Brian P. Marx, Erika J. Wolf, Mark W. Miller, Steven M. Southwick, and Robert H. Pietrzak

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keyword: PTSD

When you assess veterans' trauma histories, do you include both combat- and noncombat-related traumas? Both types are common in veterans. The prevalence of PTSD in US veterans is slightly higher than that of the general US adult population, and veterans with PTSD have higher rates of other psychiatric disorders and suicidal behaviors than veterans without PTSD. Read this CME journal article to learn what types of interventions may benefit veterans with PTSD.

Smith et al

Journal CME

Depression and Multimorbidity: A Cross-Sectional Study of 1,751,841 Patients in Primary Care

Daniel J. Smith, Helen Court, Gary McLean, Daniel Martin, Julie Langan Martin, Bruce Guthrie, Jane Gunn, and Stewart W. Mercer

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2017 | Keywords: depression, medical conditions

How do you help your patients receive coordinated medical and psychiatric care? A study of nearly 144,000 people with depression reports that 68% have at least 1 comorbid physical health condition. Read this journal CME article to see why health care systems must be structured to manage multiple conditions concurrently rather than to use a single-disease approach.

Godin et al

Journal CME

Metabolic Syndrome in a French Cohort of Patients With Bipolar Disorder: Results From the FACE-BD Cohort

Ophélia Godin, Bruno Etain, Chantal Henry, Thierry Bougerol, Philippe Courtet, Leroux Mayliss, Christine Passerieux, Jean-Michel Azorin, Jean-Pierre Kahn, Sebastien Gard, Dominique Costagliola, and Marion Leboyer for the FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: bipolar disorder, medical conditions, None, None

Nearly 1 in 5 of your patients with bipolar disorder may have metabolic syndrome (MetS), and 16% to 36% may have components of it. Do you regularly assess patients for these abnormalities? Read this journal CME activity to learn about MetS risk factors and the need for integrated psychiatric and primary care for these patients.

Madsen et al

Journal CME

Postdeployment Suicidal Ideations and Trajectories of Posttraumatic Stress Disorder in Danish Soldiers: A 3-Year Follow-Up of the USPER Study

Trine Madsen, Karen-Inge Karstoft, Mette Bertelsen, and Søren Bo Andersen

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2017 | Keywords: PTSD, None, None, None

Could the course of illness of posttraumatic stress disorder (PTSD) affect suicidal ideation among veterans? Read this CME activity from The Journal of Clinical Psychiatry to find out how rates of suicidal ideation differed among veterans with varying trajectories of PTSD over more than 2 and a half years.

Mittal et al

Journal CME

Demographic, Economic, and Clinical Correlates of Depression Treatment Response in an Underserved Primary Care Population

Dinesh Mittal, Lakshminarayana Chekuri, Liya Lu, and John C. Fortney

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: depression, None, None, None

Can you predict your patients' depression treatment response using demographic, clinical, and socioeconomic variables? Read this CME activity from The Journal of Clinical Psychiatry to learn the results of a study of response to collaborative care for depression in federally qualified health centers.

Hackman et al

Journal CME

Prescription Drug Monitoring Program Inquiry in Psychiatric Assessment: Detection of High Rates of Opioid Prescribing to a Dual Diagnosis Population

Daniel T. Hackman, Marion S. Greene, Taya J. Fernandes, Ashley M. Brown, Eric R. Wright, and R. Andrew Chambers

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2017 | Keywords: substance use disorders, None, None, None

How can you help to diminish the epidemic of prescription drug abuse, which is disproportionately affecting those with mental illness? In this CME article from The Journal of Clinical Psychiatry, learn why prescription drug monitoring program databases are powerful tools to recognize high frequencies of patient exposure to prescribed opioids and other drugs that are frequently abused.

Clinebell et al

Journal CME

Guidelines for Preventing Common Medical Complications of Catatonia: Case Report and Literature Review

Kimberly Clinebell, Pierre N. Azzam, Priya Gopalan, and Roger Haskett

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: medical conditions, mental illness, bipolar disorder, schizophrenia

Catatonia places patients at risk for a wide range of medical complications ranging from mildly painful to potentially fatal. Read this CME case and literature review to learn about preventing and managing deep vein thrombosis and pulmonary embolism, pressure ulcers, muscular contractures, and nutritional deficiencies in inpatients with catatonia.

Gaynes et al

Journal CME

Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression: A Systematic Review and Meta-Analysis

Bradley N. Gaynes, Stacey W. Lloyd, Linda Lux, Gerald Gartlehner, Richard A. Hansen, Shannon Brode, Daniel E. Jonas, Tammeka Swinson Evans, Meera Viswanathan, and Kathleen N. Lohr

Activity | Posttest | Credits: 1.00 | Expires: 5/31/2017 | Keywords: depression, None, None, None

When your patients' major depressive disorder has not remitted after 2 antidepressant trials of adequate dose and duration, do you consider repetitive transcranial magnetic stimulation (rTMS)? Read this CME activity from The Journal of Clinical Psychiatry for a review of available studies on the use of rTMS in patients with treatment-resistant depression.

Sara et al

Journal CME

The Impact of Cannabis and Stimulant Disorders on Diagnostic Stability in Psychosis

Grant E. Sara, Philip M. Burgess, Gin S. Malhi, Harvey A. Whiteford, and Wayne C. Hall

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2017 | Keywords: schizophrenia, substance use disorders, None, None

Nearly half of initial diagnoses of drug-induced psychosis are later revised to schizophrenia. In this journal CME article, find out how cannabis and stimulants affect diagnostic stability in patients with psychosis.

Simhandl et al

Journal CME

A Prospective 4-Year Naturalistic Follow-Up of Treatment and Outcome of 300 Bipolar I and II Patients

Christian Simhandl, Barbara König, and Benedikt L. Amann

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2017 | Keywords: bipolar disorder, None, None, None

Two-thirds of patients with bipolar disorder relapsed during a 4-year, naturalistic follow-up. Explore this and other findings in this CME article.

Kredentser et al

Journal CME

Cause and Rate of Death in People With Schizophrenia Across the Lifespan: A Population-Based Study in Manitoba, Canada

Maia S. Kredentser, Patricia J. Martens, Harvey M. Chochinov, and Heather J. Prior

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2017 | Keywords: schizophrenia, medical conditions, None, None

Do you screen your patients with schizophrenia for suicidal ideation and medical illnesses? Although suicide is a frequent cause of death, lung and other cancers, respiratory illness, and circulatory illness are also more likely to cause death in patients with schizophrenia than in those without. Read this journal CME study to examine changes in mortality risk over the lifespan.

Chi-Shin Wu et al

Journal CME

Long-Term Antidepressant Use and the Risk of Type 2 Diabetes Mellitus: A Population-Based, Nested Case-Control Study in Taiwan

Chi-Shin Wu, Susan Shur-Fen Gau, and Mei-Shu Lai

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2017 | Keywords: depression, anxiety, None, None

Could your patients who use antidepressants long-term have an increased risk of developing diabetes? Does age or type of antidepressant influence risk? Find out in this CME article.

Rosen et al

Journal CME

Do Benzodiazepines Reduce the Effectiveness of Exposure Therapy for Posttraumatic Stress Disorder?

Craig S. Rosen, Mark A. Greenbaum, Paula P. Schnurr, Tyson H. Holmes, Penny L. Brennan, and Matthew J. Friedman

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2016 | Keywords: PTSD, anxiety, None, None

Benzodiazepines are often prescribed to PTSD patients for disturbed sleep or other anxiety disorders. Do they reduce the efficacy of exposure therapy? Find out in this CME article.

Sin and Norman

Journal CME

Psychoeducational Interventions for Family Members of People With Schizophrenia: A Mixed-Method Systematic Review

Jacqueline Sin and Ian Norman

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2016 | Keywords: schizophrenia, None, None, None

When you provide psychoeducation for family members of your patients with schizophrenia, when do you provide it and what format do you use? Read this CME activity in The Journal of Clinical Psychiatry to learn about elements of psychoeducational interventions that have earned participants' satisfaction.

Cohen et al

Journal CME

Posttraumatic Stress Disorder and Cognitive Function: Findings From the Mind Your Heart Study

Beth E. Cohen, MD, MAS (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2016 | Keywords: PTSD, depression, dementia, None

Read this journal CME study to discover associations between PTSD and cognitive function so that you can help patients minimize modifiable risk factors.

Zimmerman et al

Journal CME

Distinguishing Bipolar II Depression From Major Depressive Disorder With Comorbid Borderline Personality Disorder: Demographic, Clinical, and Family History Differences

Mark Zimmerman, Jennifer H. Martinez, Theresa A. Morgan, Diane Young, Iwona Chelminski, and Kristy Dalrymple

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2016 | Keywords: bipolar depression, personality disorders, depression, bipolar disorder

Distinguishing between bipolar II depression and MDD with comorbid borderline personality disorder is challenging. Learn about differential variables.

Yoon et al

Journal CME

Impact of the Number of Parents With Alcohol Use Disorder on Alcohol Use Disorder in Offspring: A Population-Based Study

Gihyun Yoon, Joseph Westermeyer, Michael A. Kuskowski, and Laura Nesheim

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2016 | Keywords: substance use disorders, None, None, None

New! Learn about the role of parental alcohol use disorder (AUD) as a risk factor for AUD in offspring.

Salvatore, et al

Journal CME

Predicting Diagnostic Change Among First-Episode Patients Diagnosed With DSM-IV Major Depression With Psychotic Features

Paola Salvatore, Ross J. Baldessarini, Hari-Mandir K. Khalsa, Mario Amore, Cristina Di Vittorio, Gabriella Ferraro, Carlo Maggini, and Mauricio Tohen

Activity | Posttest | Credits: 1.00 | Expires: 7/31/2016 | Keywords: depression, bipolar depression, bipolar disorder, None

Discover how to accurately diagnose depression with psychotic features.

Nielsen et al

Journal CME

Termination of Clozapine Treatment Due to Medical Reasons: When Is It Warranted and How Can It Be Avoided?

Jimmi Nielsen, Christoph U. Correll, Peter Manu, and John M. Kane

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2016 | Keywords: schizophrenia, bipolar disorder, None, None

Learn how to manage adverse effects and discover when to stop clozapine treatment.

Withers et al

Journal CME

Is Depression With Atypical Features Associated With Trauma History?

Amy C. Withers, Jenna M. Tarasoff, and Jonathan W. Stewart

Activity | Posttest | Credits: 1.00 | Expires: 5/31/2016 | Keywords: atypical depression, PTSD, None, None

In this journal article, learn about the link between atypical depression and trauma history, which may be more complex than prior research has outlined.

+Improving the Care and Management of Patients With Inadequate Response to Depression Treatment [Series Home Page]

Roger S. McIntyre

Case & Comment

Implementing Appropriate Treatment Strategies for Varying Types of Depression

Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2018 | Keywords: depression, bipolar disorder, anxiety

What steps should be taken when your patient does not respond adequately to antidepressant medication and has symptoms that may indicate the presence of several diagnoses? Review this Case and Comment activity to analyze the case of Melissa, an architect whose treatment-resistant depression may be masking other diagnoses.

Bradley Gaynes

Case & Comment

Recognizing and Assessing Risk Factors for Difficult-to-Treat Depression and Treatment-Resistant Depression

Bradley Gaynes, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2018 | Keyword: depression

What should you do when your patients do not respond adequately to antidepressant therapy? Review this new Case and Comment activity to learn more about Alice's depressive episode and how you can help your patients like Alice achieve remission.

Bradley Gaynes (Chair), et al

Journal Supplement

Improving the Care and Management of Patients With Inadequate Response to Depression Treatment

Bradley Gaynes, MD, MPH (Chair), et al

Activity | Posttest | Credits: 2.50 | Expires: 1/31/2018 | Keyword: depression

With only about one-third of patients with depression responding to their initial treatment trial, clinicians face the challenge of managing patients with poor response or treatment-resistant depression. In this Supplement, learn to identify difficult-to-treat types of depression, to select evidence-based treatments, to adjust treatment in a timely manner, and to coordinate care of comorbid conditions to improve patient outcomes.

+Companion CME Activities [Series Home Page]

Weinreb et al

PCC CME

Managing Depression Among Homeless Mothers: Pilot Testing an Adapted Collaborative Care Intervention

Linda Weinreb, Carole C. Upshur, Debbian Fletcher-Blake, George Reed, and Christine Frisard

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2018 | Keyword: depression

Homeless mothers have high rates of mental and physical health problems and often have had multiple traumatic experiences. Although depression is common, most homeless mothers do not receive treatment for it. Therefore, targeting this population for depression screening in primary care settings, including shelter-based clinics, has the potential to more readily engage these women in treatment for depression and their other medical and mental health issues. Read this CME article to learn more.

Burke et al

PCC CME

Movements and Memory

Anna D. Burke, Garret H. Riggs, David A. Weidman, Helle Brand, and William J. Burke

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2018 | Keyword: dementia

Follow along as Mr A, an 82-year-old man with cognitive impairment, is evaluated and treated. His symptoms include getting lost while driving, forgetting conversations and events, and having disturbed sleep. Mr A also has mild tremors in his hands and some dizziness. What are the best diagnosis and treatments for Mr A?

Chakravorty et al

PCC CME

Sleep Duration and Insomnia Symptoms as Risk Factors for Suicidal Ideation in a Nationally Representative Sample

Subhajit Chakravorty, H.Y. Katy Siu, Linden Lalley-Chareczko, Gregory K. Brown, James C. Findley, Michael L. Perlis, and Michael A. Grandner

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keywords: sleep disorders, depression

Do you screen for depressive disorder and suicidal ideation in patients complaining of insomnia and abnormal sleep duration? Read this journal CME article to learn about recent research on this topic.

Czech et al

PCC CME

Association Between Specific Depression Symptoms and Glycemic Control Among Patients With Comorbid Type 2 Diabetes and Provisional Depression

Stephanie J. Czech, Susan M. Orsillo, Paul A. Pirraglia, Thomas M. English, and Alexa J. Connell

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: depression, medical conditions, insomnia

Do you treat patients with type 2 diabetes who also have depression? Did you know that assessing and managing sleep problems might improve glycemic control in these patients? Read this journal CME article for more information.

Madan et al

PCC CME

Reducing Adverse Polypharmacy in Patients With Borderline Personality Disorder: An Empirical Case Study

Alok Madan, John M. Oldham, Sylvia Gonzalez, and J. Christopher Fowler

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: personality disorders, medical conditions

How can outcomes be improved in patients with borderline personality disorder? Have you considered that reducing polypharmacy could help? Read this CME journal case study to follow a patient's symptoms and well-being as her medication regimen is simplified from admission to discharge and afterwards.

Flynn et al

PCC CME

Wernicke’s Encephalopathy: Increasing Clinician Awareness of This Serious, Enigmatic, Yet Treatable Disease

Alexandra Flynn, Matthew Macaluso, Inna D’Empaire, and Megan M. Troutman

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: medical conditions, mental illness, substance use disorders

Permanent brain damage, long-term institutionalization, and death can result from undiagnosed and untreated Wernicke’s encephalopathy. Too many cases are not diagnosed until autopsy. Do you know which patients are at risk? Read this journal CME article to review the clinical diagnosis and effective treatment for this medical emergency.

Harward et al

PCC CME

Impact of a US Food and Drug Administration Drug Safety Communication on Zolpidem Dosing: An Observational Retrospective Cohort

Jonathan L. Harward, Valerie B. Clinard, Michael R. Jiroutek, Beverly H. Lingerfeldt, and Andrew J. Muzyk

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2017 | Keywords: insomnia, sleep disorders

Did you know that recommended dosing levels for zolpidem were lowered in 2013 due to risk of next-day driving impairment in up to 1 of 3 women and 1 of 4 men? Data from one pharmacy chain show that only 16% of new precriptions matched the lower dosing recommendations. Read this journal CME article to find out how you can improve patient and public safety.

Nynas et al

PCC CME

Depression and Anxiety Following Early Pregnancy Loss: Recommendations for Primary Care Providers

Johnna Nynas, Puneet Narang, Murali K. Kolikonda, and Steven Lippmann

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2017 | Keywords: depression, anxiety, medical conditions

How do you address psychological concerns in your patients who have experienced a miscarriage? Emotional distress usually follows early pregnancy loss. This reaction tends to improve over time, but women should be screened for depression and anxiety in case a formal evaluation and treatment are warranted. Read this journal CME activity to learn more.

Shahla Mohsenin and Vahid Mohsenin

PCC CME

Diagnosis and Management of Sleep Disorders in Posttraumatic Stress Disorder: A Review of the Literature

Shahla Mohsenin, MD, and Vahid Mohsenin, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keywords: PTSD, sleep disorders

How well are sleep problems being managed in your patients with PTSD? Insomnia, nightmares, sleep apnea, and sleep movement disorders are common in these patients. Read this journal CME activity to learn about diagnosing and managing these conditions so that you can better help your patients with PTSD.

Shane J. McInerney and Sidney H. Kennedy

PCC CME

Review of Evidence for Use of Antidepressants in Bipolar Depression

Shane J. McInerney, MB, MSc, MRCPsych, and Sidney H. Kennedy, MD, FRCPC

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2017 | Keywords: bipolar depression, None, None, None

Antidepressants are used in up to 50% of patients with bipolar depression. Do you prescribe them for your patients? Read this brief review to find out whether antidepressants work in bipolar depression and whether any benefits exceed risks, such as induction of (hypo)mania and rapid cycling.

Blasco-Fontecilla et al

PCC CME

A Cross-Sectional Study of Major Repeaters: A Distinct Phenotype of Suicidal Behavior

Hilario Blasco-Fontecilla, MD, PhD; Isabelle Jaussent, PhD; Emilie Olié, MD, PhD; Severine Béziat, MSc; Sebastien Guillaume, MD, Paula Artieda-Urrutia, Enrique Baca-Garcia, Jose de Leon, and Philippe Courtet

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: substance use disorders, eating disorders, depression, None

Can people become addicted to suicidal behavior? Do individuals who attempt suicide 5 times or more represent a distinct phenotype among those with suicidal behavior? Read this journal CME article to learn more about the demographic and clinical characteristics of patients who repeatedly attempt suicide.

Ionescu et al

PCC CME

Pharmacologic Treatment of Dimensional Anxious Depression: A Review

Dawn F. Ionescu, Mark J. Niciu, Erica M. Richards, and Carlos A. Zarate, Jr

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: depression, anxiety, None, None

Did you know that anxious symptoms affect about half of patients with depression? To note the effects of anxiety within depression, the DSM-5 added an “anxious distress” specifier to the diagnosis of major depressive disorder. In this CME activity from The Primary Care Companion, read about the outcomes and side effect burden associated with anxious depression.

Hu et al

PCC CME

Mixed Specifier for Bipolar Mania and Depression: Highlights of DSM-5 Changes and Implications for Diagnosis and Treatment in Primary Care

Jia Hu, Rodrigo Mansur, and Roger S. McIntyre

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2017 | Keywords: bipolar depression, bipolar disorder, bipolar mania, None

Unlike the DSM-IV-TR, the DSM-5 allows patients with subsyndromal mixed symptoms to receive a diagnostic specifier for mixed features, which may reduce the frequent misdiagnosis of bipolar disorder and improve treatment. Read about the diagnostic changes and the implications for treatment in this Primary Care Companion journal CME article.

Das et al

PCC CME

Out of Sight, Out of Mind: The Case of a 62-Year-Old Man With Visual Complaints and Cognitive Decline

Saurav Das, Adam S. Fleisher, Roy Yaari, James D. Seward, Anna D. Burke, Helle Brand, and Pierre N. Tariot

Activity | Posttest | Credits: 1.00 | Expires: 2/28/2017 | Keywords: Alzheimer's, dementia, depression, medical conditions

Have any patients come to you with vision problems that their eye doctors can't solve? Read this Primary Care Companion interactive case report to learn about how these symptoms may be indicative of a variant of Alzheimer's disease or a precursor. Diagnostic tests and potential treatments are discussed.

Burke et al

PCC CME

Hypersexuality in Dementia

Anna D. Burke, Roy Yaari, Pierre N. Tariot, Adam S. Fleisher, Geri R. Hall, and Helle Brand

Activity | Posttest | Credits: 1.50 | Expires: 10/31/2016 | Keywords: dementia, None, None, None

Have you tried treating hypersexuality in patients with dementia? Although up to a fifth of patients with dementia have sexually disinhibited behaviors, no approved treatments are available. Read this case study to get treatment ideas from experts at the Banner Alzheimer's Institute.

Yaari et al

PCC CME

Preserving Independence

Roy Yaari, Anna D. Burke, Helle Brand, James D. Seward, and Pierre N. Tariot

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2016 | Keywords: Alzheimer's, dementia, depression, insomnia

Participate in this CME case study to diagnose and manage Ms A, an 84-year-old woman whose cognitive changes began about 1 year ago.

Yaari et al

PCC CME

A Rapid Turn of Events: Sudden Physical and Cognitive Decline

Roy Yaari, Susy Favaro, Anna D. Burke, Helle Brand, Adam S. Fleisher, James D. Seward, Jan Dougherty, and Pierre N. Tariot

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2016 | Keywords: dementia, None, None, None

Explore the appropriate workup, differential diagnosis, and care for a rapidly progressive dementia in a 57-year-old man.

+Test Series [Series Home Page]

+Achieving Remission and Recovery in Depression With Anxiety [Series Home Page]

Andrew Cutler

Psychlopedia

The Role of Insomnia in Depression and Anxiety: Its Impact on Functioning, Treatment, and Outcomes

Andrew J. Cutler, MD

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2018 | Keywords: depression, insomnia, anxiety

The case of 42-year-old Mrs C illustrates the common combination of anxious depression and sleep problems. In this activity, learn about the relationship between these disorders and find effective strategies to treat insomnia with depression and anxiety.

David Sheehan

Psychlopedia

Importance of Restoring Function in Patients With Major Depressive Disorder

David V. Sheehan, MD, MBA

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2018 | Keyword: depression

Restoring function in areas like home, work, and relationships is an important treatment goal for patients with depression. Here, find practical rating scales to monitor areas of functioning and discover specific interventions to target these impairments.

Larry Culpepper

Psychlopedia

Impact of Anxious Symptoms and Comorbid Anxiety Disorders on Functional Impairment in Depressed Patients

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2018 | Keywords: depression, anxiety

Explore this activity to understand the relationship between, and impact of, depression and anxiety, and discover strategies to assess and treat both depressive and anxious symptoms in your patients.

+Measuring and Managing Cognitive Impairment in Schizophrenia [Series Home Page]

S. Charles Schulz (Chair), et al

Journal Supplement

Measuring and Managing Cognitive Impairment in Schizophrenia

S. Charles Schulz, MD (Chair), et al

Activity | Posttest | Credits: 2.00 | Expires: 2/28/2018 | Keyword: schizophrenia

Cognitive impairment is present in almost all patients with schizophrenia, yet it often receives less clinical attention than positive and negative symptoms. Read this supplement to help identify, monitor, and manage these symptoms in your patients.

+Sleep Disorders in the Psychiatric Setting [Series Home Page]

Krystal and Sorscher

Webcast

Recognizing and Managing Insomnia in Primary Care and Specialty Settings

Andrew D. Krystal, MD, MS (chair), and Adam J. Sorscher, MD

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2019 | Keyword: insomnia

Watch this webcast to see two patient cases with different sleep difficulties. Listen as the faculty discuss these cases and give evaluation tools and treatment strategies that will help you manage patients with sleep problems in your own practice.

+Biological Therapies in Psychiatry 2015 [Series Home Page]

+Strategies to Improve Outcomes for Primary Care Patients With Major Depressive Disorder [Series Home Page]

Rakesh Jain et al

PCC CME

Improving Outcomes for Primary Care Patients With Depression

Rakesh Jain, MD, MPH (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keyword: depression

How do you assess symptom resolution, treatment adherence, and tolerability in your patients with depression? Follow the 3 patient cases in this CME newsletter to learn how measurement-based care can help you monitor treatment, improve adherence and patient outcomes, and recognize and treat residual symptoms.

C. Brendan Montano

Psychlopedia

Tactics to Improve Adherence in Depressed Primary Care Patients

C. Brendan Montano, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: depression

Do your patients with depression have trouble with medication adherence? Follow as Mr K, a 28-year-old patient, stops adhering to his antidepressant due to adverse effects, and learn techniques for questioning your patients, collecting their information, and providing them with clear instructions to improve adherence.

W. Clay Jackson

Psychlopedia

The Benefits of Measurement-Based Care for Primary Care Patients With Depression

W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keyword: depression

What treatment strategies do you consider for your patients who fail to respond to initial antidepressant treatment? Read the case of Mrs C to see how measurement-based care helps confirm her diagnosis, track symptom response, and assess her sense of well-being and to learn strategies for treating suboptimal response.

Rakesh Jain, MD, MPH

Psychlopedia

The Identification and Resolution of Residual Symptoms in Depressed Primary Care Patients

Rakesh Jain, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2017 | Keyword: depression

Like many patients being treated for depression, 86-year-old Mrs J does not recognize the residual symptoms she is experiencing. Follow her case as her psychiatrist uses several tools including rating scales and collateral information to identify her continuing symptoms and then considers different treatment strategies based on her age and symptoms.

Rakesh Jain et al

Podcast

Resolving Residual Symptoms in Primary Care Patients With Depression

Rakesh Jain, MD, MPH (chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: depression, sleep disorders

In this CME podcast, listen to experts discuss the case of Mrs J, an elderly woman with a history of depression. She has reported insomnia and has requested a benzodiazepine to help her sleep. Although she claims that her depressed mood is well controlled, her husband reports differently. The experts review her treatment options, taking into account both her symptoms and her age.

Rakesh Jain et al

Podcast

Improving Adherence in Primary Care Patients With Depression

Rakesh Jain, MD, MPH (chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: depression, bipolar depression

In this CME podcast, listen to experts discuss the case of Mr K, a health 28-year-old man who has never needed medical care previously. He has recently lost his job and developed a major depressive episode that has complicated features. The experts review his objective screening and monitoring instrument results as well as possible steps to take that will help alleviate Mr K’s problematic symptoms.

Rakesh Jain et al

Podcast

Saving Time With Measurement-Based Care for Depression in Primary Care

Rakesh Jain, MD, MPH (chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keyword: depression

In this CME podcast, listen to experts discuss the case of Mrs C, a 38-year-old married woman with depression who does not respond to initial antidepressant treatment. Next-step strategies for identifying the cause of nonresponse and tips for how to best monitor patients are discussed.

+Complicated Major Depressive Disorder [Series Home Page]

+What Psychiatric Nurses Need to Know About Bipolar Disorder [Series Home Page]

Joanne Iennaco and Julie Carbray

Game Case

Engaging Patients in Long-Term Management of Bipolar Disorder

Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN, and Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2017 | Keyword: bipolar disorder

What strategies do you use to get patients with bipolar disorder to participate in their illness management? Play this game-based activity to see if you can help a long-term patient with bipolar disorder learn the importance of adhering to treatment, tracking mood states, and making important lifestyle changes.

Joanne Iennaco and Julie Carbray

Game Case

Communicating With Colleagues and Patients About Acute Bipolar Disorder

Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN, and Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: bipolar disorder, bipolar mixed episodes

Play your way to CME credit! This game-based activity lets you test your knowledge of assessment tools, treatment response, and patient education as you help 24-year-old Kate recover from her latest bipolar episode.

Julie Carbray and Joanne Iennaco

Game Case

Recognizing Signs and Symptoms of Bipolar Disorder

Julie A. Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, and Joanne DeSanto Iennaco, PhD, PMHNP-BC, APRN

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: bipolar disorder, bipolar mixed episodes

This activity lets you earn CME credit and learn the signs and symptoms of bipolar disorder—while playing games! You’ll follow the case of David, a 20-year-old college student while uncovering rating scales and diagnostic criteria that can help with patient assessment.

+Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression [Series Home Page]

Thomas Schwartz

Case & Comment

Why Is Mechanism of Action Important in Antidepressant Treatment?

Thomas L. Schwartz, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: depression

How do you handle patients who do not respond adequately to SSRI treatment? Explore this new Case and Comment to compare Maria's response to different antidepressant medications and learn more about how to effectively choose a therapeutic strategy for your patients.

Michael E. Thase

Case & Comment

How Does Understanding Mechanism of Action Help Clinicians Personalize Antidepressant Treatment Choices?

Michael E. Thase, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keywords: depression, bipolar depression

Patients may experience a symptom profile that changes over time, such as a patient who first appears to have unipolar depression but later exhibits signs of mania or hypomania. Here, follow the case of Adam, a 30-year-old man, who is experiencing a recurrence of depression, and track his response through several antidepressant trials.

Michael E. Thase

Case & Comment

What Are the Mechanisms of Action of Current Antidepressant Treatments?

Michael E. Thase, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: depression

Therapeutic effects of antidepressants may vary greatly from patient to patient, with some patients failing to respond after several treatment trials. In this Case and Comment activity, follow the treatment steps taken for a 62-year-old surgeon with a treatment-resistant depressive episode.

Michael E. Thase, MD (Chair), et al

Journal CME

Choosing Medications for Treatment-Resistant Depression Based on Mechanism of Action

Michael E. Thase, MD (Chair), and Thomas L. Schwartz, MD

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keyword: depression

What can you do for your patients with depression who show partial response or no response to treatment? Follow a discussion by expert faculty about how altering levels of dopamine, norepinephrine, and serotonin in the brain may theoretically target specific depressive symptoms and how the mechanisms of action of different antidepressant classes are associated with therapeutic benefits and adverse effects.

Michael E. Thase and Thomas L. Schwartz

Webcast

Using Mechanism of Action to Choose Medications for Treatment-Resistant Depression

Michael E. Thase, MD (chair), and Thomas L. Schwartz, MD

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2017 | Keyword: depression

Do you know how antidepressant classes can complement each other through different mechanism of action? Watch this webcast to learn the mechanism of action of various antidepressant classes and how to apply that knowledge to your patients with depression.

+Barriers to Remission in Major Depressive Disorder: Residual Symptoms, Functional Impairment, and Medication Mechanism of Action [Series Home Page]

Pierre Blier

Psychlopedia

Neurobiology of Depression and Mechanism of Action of Depression Treatments

Pierre Blier, MD, PhD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keyword: depression

Antidepressants, including SSRIs, may alleviate depressive symptoms but leave residual symptoms. In this activity, discover the mechanism of action of antidepressants and adjunctive agents and how to choose effective strategies to target specific symptoms or block/activate specific receptors for broader therapeutic benefits.

Larry Culpepper

Psychlopedia

Functional Impairment and Improvement in Depression

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keyword: depression

Unresolved symptoms of depression can cause functional impairment and negatively affect patients' work performance, home life, and relationships. In this Psychlopedia activity, learn how to assess functional impairments using validated rating scales and to address contributors to functional impairment.

Andrew A. Nierenberg, MD

Psychlopedia

Residual Symptoms in Depression: Prevalence and Impact

Andrew A. Nierenberg, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keyword: depression

While mood symptoms may remit in your patients with depression, lack of motivation and negative affect may keep patients from achieving full recovery. Here, learn how these residual symptoms hinder your patients' function and discover tools to assess quality of life and positive affect.

+Criminal Forensic Psychiatry [Series Home Page]

Scott Freeman

Psychlopedia

Criminal Forensic Psychiatry: A Primer for Psychiatrists

Scott A. Freeman, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keyword: mental illness

How is mental illness assessed and treated within the judicial system? Many mentally ill people spend time in correctional settings, and psychiatrists are involved in their evaluation and treatment. Participate in this Psychlopedia activity to find out about competency to stand trial and the insanity defense.

+Cognition in the Depressed Patient [Series Home Page]

George I. Papakostas, MD

Psychlopedia

Components of Cognitive Functioning and Their Measurement

George I. Papakostas, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keyword: depression

Do you regularly assess cognition in your patients with depression? Read this Psychlopedia activity to learn about validated scales for assessing cognition in MDD in clinical trials and in practice.

George I. Papakostas and Larry Culpepper

Journal CME

Understanding and Managing Cognition in the Depressed Patient

George I. Papakostas, MD (Chair), and Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2017 | Keyword: depression

Patients with MDD may experience cognitive dysfunctions that make recovery difficult or incomplete. Read this new Academic Highlights to learn to understand and identify problems with cognition in depressed patients, and to learn new antidepressant therapies that improve all areas of cognition.

George I. Papakostas

Psychlopedia

Antidepressants and Their Effect on Cognition in Major Depressive Disorder

George I. Papakostas, MD (Chair)

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keyword: depression

Do you consider cognitive symptoms when selecting a medication for major depressive disorder? Discover how to use cognitive scales to evaluate patient symptoms and needs, and understand the effects of various antidepressant medications on cognition.

Larry Culpepper

Psychlopedia

Impact of Untreated Major Depressive Disorder on Cognition and Daily Function

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keyword: depression

Cognitive symptoms may be present before your patients experience a first depressive episode and linger between episodes and even after remission of mood symptoms. Read this new Psychlopedia activity to learn which cognitive symptoms will likely affect your patients with MDD, when these symptoms may occur, and how they may hinder patients at home, work, or school.

Larry Culpepper

Psychlopedia

Neuroanatomy and Physiology of Cognition

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keyword: depression

New research on brain networks provides insight into cognitive deficits prevalent in patients with depression. Explore this Psychlopedia activity to discover how disrupted connections and functions in various brain networks and regions contribute to cognitive symptoms and how new treatments are needed for these symptoms.

+Recognizing and Treating Excessive Daytime Sleepiness and Narcolepsy [Series Home Page]

Russell Rosenberg

Psychlopedia

Clinical Assessment of Excessive Daytime Sleepiness in the Diagnosis of Sleep Disorders

Russell P. Rosenberg, PhD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: narcolepsy, sleep disorders

Physicians who are not sleep specialists often feel they lack knowledge about sleep disorders. Read this Psychlopedia activity to familiarize yourself with disorders associated with excessive daytime sleepiness and the assessment methods used to diagnose these disorders.

Russell Rosenberg

Psychlopedia

Recommended Treatment Strategies for Patients With Excessive Daytime Sleepiness

Russell P. Rosenberg, PhD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: narcolepsy, sleep disorders

Given the prevalence of sleep disorders, too few sleep specialists are available. Therefore, other health care providers, especially primary care clinicians, need to know about the diagnosis of sleep disorders and the therapeutic options available to treat them. Read this Psychlopedia activity to increase your ability to select appropriate treatment strategies for sleep disorders.

Thomas Roth, PhD

Psychlopedia

The Effect of Comorbid Psychiatric and Medical Illnesses on Sleep Disorder Treatment

Thomas Roth, PhD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: narcolepsy, sleep disorders

Unrecognized conditions may be contributing to symptoms of daytime sleepiness and/or fatigue in your patients with sleep disorders. Learn about psychiatric, neurologic, and medical conditions that frequently coexist with sleep disorders and discover treatment strategies, both pharmacologic and nonpharmacologic, to improve patient outcomes.

Thomas Roth, PhD

Psychlopedia

Effects of Excessive Daytime Sleepiness and Fatigue on Overall Health and Cognitive Function

Thomas Roth, PhD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: narcolepsy, sleep disorders

Excessive daytime sleepiness (EDS) and fatigue can lead to accidents or unemployment if left unrecognized and untreated in your patients. In this Psychlopedia activity, discover patient-report scales and objective measures to screen for these symptoms and learn to recognize common disorders that may cause or contribute to EDS/fatigue.

+Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective [Series Home Page]

Susan L. McElroy, MD (chair), and Anna I. Guerdjikova, PhD, LISW, CCRC

Webcast

Understanding and Coping With Binge Eating Disorder: The Patient’s Perspective

Susan L. McElroy, MD (chair), and Anna I. Guerdjikova, PhD, LISW, CCRC

Activity | Posttest | Credits: 1.00 | Expires: 6/30/2017 | Keywords: eating disorders, depression

Patients with BED will likely seek treatment for another problem like depression or weight loss rather than admit their eating behaviors. Watch this webcast to learn how to assess for and diagnose BED in patients with comorbid conditions and to understand the current pharmacologic and nonpharmacologic treatment options available for patients with this condition.

+Overcoming Challenges in the Diagnosis and Management of ADHD in African American Adults [Series Home Page]

Rostain et al

Journal CME

Culturally Competent Strategies for Assessing and Treating ADHD in African American Adults

Anthony L. Rostain, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keyword: ADHD

African American adults may not recognize their symptoms of ADHD because they have developed coping strategies. Explore this Commentary to learn about the prevalence of and assessment tools for ADHD in African American adults and to choose an individualized approach to treatment that is sensitive to your patients' background and current needs.

Rostain et al

Journal CME

Cultural Background and Barriers to Mental Health Care for African American Adults

Anthony L. Rostain, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 3/31/2017 | Keyword: ADHD

Over one-third of African American adults may not receive treatment for serious mental illnesses. Read this new Commentary to discover how the history of psychiatry and African Americans may contribute to attitudes of fear and mistrust regarding diagnosis and treatment and how these and other barriers to care may be addressed to improve the mental health care of your African American patients.

Anthony L. Rostain

Psychlopedia

Health Care–Seeking Behaviors of African American ADHD Patients and Their Families: Overcoming Economic and Cultural Barriers

Anthony L. Rostain, MD

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2017 | Keywords: ADHD, None, None, None

Do you know what keeps many African American patients from seeking treatment for mental health conditions? Read this new Psychlopedia activity to learn about barriers your African American patients face when seeking mental health services and to implement strategies to improve their care.

Roberta Waite

Psychlopedia

Culturally Competent Approaches to Assessing ADHD in African American Adults and Overcoming Cultural Issues With Patients and Families

Roberta Waite, EdD, PMHCNS-BC, FAAN

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

The history of racism within the field of psychiatry still affects African American patients today, making it difficult to diagnose psychiatric illness. Read this Psychlopedia to assess patients’ resistance toward psychiatric treatment in a culturally informed way and to better diagnose and treat African American patients with ADHD.

J. Russell Ramsay

Psychlopedia

Health Care Systems Issues and Disparities in ADHD Care for African American Adults

J. Russell Ramsay, PhD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

African American adults with ADHD are underdiagnosed and undertreated. Explore this activity to learn about issues involving the health care system and disparities in care for African American adults, and discover how you can further assess patient and provider cultural biases toward ADHD symptoms and treatment.

+Cause and Effect in Bipolar Depression: Misdiagnosis Leads to Inappropriate Treatment, Clinical Complications, and Adverse Outcomes [Series Home Page]

Henry A. Nasrallah

Psychlopedia

Consequences of Misdiagnosis: Inaccurate Treatment and Poor Patient Outcomes in Bipolar Disorder

Henry A. Nasrallah, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keyword: bipolar disorder

Misdiagnosis of bipolar depression can create a cascade of negative outcomes for patients. Read this Psychlopedia activity to understand the human costs of misdiagnosis and how to monitor depression in bipolar patients.

Henry A. Nasrallah

Psychlopedia

Setting the Stage for Success or Failure: Making an Accurate Diagnosis of Bipolar Depression

Henry A. Nasrallah, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keyword: bipolar depression

Patients with bipolar depression are too often misdiagnosed as having unipolar depression. Read this Psychlopedia activity to learn clues to aid in making the correct diagnosis and how to detect signs of bipolarity in depressed patients.

J. Sloan Manning

Psychlopedia

Effective Treatment of Bipolar Depression: Monotherapy and Combination Strategies

J. Sloan Manning, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keywords: bipolar depression, bipolar disorder

To effectively manage bipolar disorder, you need to be familiar with evidence-based pharmacotherapy. Find out which pharmacologic strategies are the most effective for bipolar depression and which agents work well as monotherapy or adjunctive therapy.

J. Sloan Manning

Psychlopedia

Measuring Patient Outcomes and Making the Transition From Acute to Maintenance Treatment for Bipolar Depression

J. Sloan Manning, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: bipolar depression, bipolar disorder

Most patients with bipolar disorder will require maintenance therapy to reduce their risk of recurrent mood episodes. Read this new Psychlopedia activity to learn tools to track depressive and manic symptoms throughout treatment and to discover which maintenance strategies are the most effective for reducing the risk of manic or depressive episodes.

+New Strategies in Sleep [Series Home Page]

+Challenges in the Recognition and Management of ADHD in Hispanic Adults in the United States [Series Home Page]

Rostain et al

Journal CME

Solutions for Treating Hispanic Adults with ADHD

Anthony L. Rostain, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keyword: ADHD

Hispanic Americans often go underserved by the mental health community, though they make up the largest minority group in the United States. Read this new Commentary to learn new strategies for approaching Hispanic patients with ADHD about diagnosis and treatment.

Rostain et al

Journal CME

Barriers to Care for Hispanic Adults With ADHD

Anthony L. Rostain, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 1/31/2017 | Keyword: ADHD

Cultural differences may hide problematic symptoms, and minority patients with ADHD can fall behind in the workplace. Read this new Commentary to learn about the treatment disparities between Hispanics and the wider population and to discover the cultural barriers that affect recognition and treatment of ADHD.

Anthony L. Rostain

Psychlopedia

Cultural Issues, Myths, Misinformation, and Health Care–Seeking Behaviors of Hispanic Patients With ADHD and Their Families

Anthony L. Rostain, MD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

About two-thirds of Hispanic people in the United States may not receive treatment for mental illnesses such as ADHD. Read this new Psychlopedia activity to learn about barriers to your Hispanic patients receiving mental health services and to acquire practical steps to address these barriers.

Juan Pedraza

Psychlopedia

Culturally Competent Approaches to Diagnosing ADHD in Hispanic Adults and Overcoming Cultural Issues With Patients and Families

Juan Pedraza, MD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2017 | Keywords: ADHD, None, None, None

Hispanics are the most prevalent and diverse minority group in the US, and treating Hispanic adults for ADHD can be difficult. Read this Psychlopedia to learn about the unique characteristics and needs of Hispanic individuals with ADHD and use this knowledge to provide culturally competent diagnosis and treatment.

Yamalis Diaz

Psychlopedia

Health Care Systems Issues and Disparities in ADHD Care for Hispanic Adults

Yamalis Diaz, PhD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: ADHD, None, None, None

Hispanic adults with ADHD encounter numerous barriers when seeking treatment. Read this Psychlopedia to learn how to assess a Hispanic patient’s cultural biases toward ADHD diagnosis and treatment options.

+Making Connections Between Science and Symptoms in Schizophrenia [Series Home Page]

John M. Kane and Christoph U. Correll

Video

Making the Link Between Science and Symptoms in Schizophrenia

John M. Kane, MD (chair), and Christoph U. Correll, MD

Activity | Posttest | Credits: 0.50 | Expires: 1/31/2017 | Keyword: schizophrenia

Standard hypotheses about the causes of schizophrenia fail to account for all types of symptoms. Watch this video to realize the importance of negative and cognitive symptoms and the limitations of current medications to adequately address those symptoms.

John M. Kane

Psychlopedia

The Role of NMDA Receptors in Schizophrenia

John M. Kane, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: schizophrenia, None, None, None

NMDA receptor function mediates the downstream release of neurotransmitters thought to be involved in schizophrenia, including dopamine, glutamate, and GABA. Here, review the function of NMDA receptors and find out about their possible role as a novel treatment target for schizophrenia.

Anissa Abi-Dargham

Psychlopedia

Schizophrenia: Overview and Dopamine Dysfunction

Anissa Abi-Dargham, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: schizophrenia, None, None, None

Excess dopamine and abnormal dopamine synthesis cause the positive symptoms of schizophrenia, but does this dysfunction also account for the negative and cognitive symptoms seen in this disorder? Here, get an overview of dopamine dysfunction and find out why this treatment target may be limited for patients with schizophrenia.

Christoph U. Correll

Psychlopedia

Mechanism of Action of Antipsychotic Medications

Christoph U. Correll, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keywords: schizophrenia, None, None, None

Do you anticipate your patients' side effects from antipsychotic treatment based on the medication's mechanism of action? Read this new Psychlopedia activity to use the pharmacology of antipsychotics to help predict their clinical activity and to learn how long to wait until a steady state concentration is reached and when dose adjustments can be made.

Jonathan M. Meyer

Psychlopedia

The Glutamate Hypothesis of Schizophrenia

Jonathan M. Meyer, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

Schizophrenia may be partially caused by deficient activity at glutamate synapses. Read this Psychlopedia activity to find out about the glutamate hypothesis to better understand the underlying neuropathology of the disorder and learn about glutamate as a potential treatment target for this illness.

Correll and Kane

Journal CME

Schizophrenia: Mechanism of Action of Current and Novel Treatments

Christoph U. Correll, MD, and John M. Kane, MD

Activity | Posttest | Credits: 1.00 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

New! Review the mechanism of action of available antipsychotics, learn why they're not effective for treating all symptoms, and find out about a potential treatment target.

Abi-Dargham and Meyer

Journal CME

Schizophrenia: The Role of Dopamine and Glutamate

Anissa Abi-Dargham, MD, and Jonathan M. Meyer, MD

Activity | Posttest | Credits: 1.00 | Expires: 3/31/2017 | Keywords: schizophrenia, None, None, None

Antipsychotics primarily address positive symptoms of schizophrenia, while disabling negative and cognitive symptoms can persist. This Commentary briefly explains the dopamine dysfunction of the disorder and how glutamate may provide possible novel targets for pharmacotherapy to more comprehensively manage the constellation of schizophrenia symptoms.

+Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

Mary K. Colvin and Theodore A. Stern

Virtual Rounds in Neurology

Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder

Mary K. Colvin, PhD, and Theodore A. Stern, MD

Activity | Posttest | Credits: 1.00 | Expires: 12/31/2017 | Keyword: ADHD

Have you wondered how you could reliably make a diagnosis of ADHD and differentiate it from a learning disorder or another psychiatric condition? If you have, then this case vignette and discussion should prove useful in your evaluation and management of patients and their families.

+Biological Therapies in Psychiatry 2014 [Series Home Page]

+Treating and Caring for the Patient With Moderate-to-Severe Alzheimer's Disease [Series Home Page]

William J. Burke

Neurology Reports

Managing Patients With Moderate-to-Severe Alzheimer’s Disease: Expectations, Treatments, and Prognosis

William J. Burke, MD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2017 | Keywords: Alzheimer's, None, None, None

In this Neurology Report, experts from Banner Alzheimer’s Institute summarize ways to effectively communicate with patients and caregivers about an Alzheimer’s disease diagnosis and prognosis. Plus, they cover how to select appropriate treatments to slow functional decline and manage troublesome behavioral and psychological symptoms.

Jan Dougherty

Neurology Reports

Effective Communication Strategies to Help Patients and Caregivers Cope With Moderate-to-Severe Alzheimer’s Disease

Jan Dougherty, RN, MS

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: Alzheimer's, None, None, None

Language impairment may cause more difficulty than memory impairment among caregivers and patients with Alzheimer's disease. Gain knowledge of ways to educate caregivers about communication problems, mistakes to avoid, and effective strategies to improve communication.

+The Impact of Oral Medications on the Treatment of Multiple Sclerosis [Series Home Page]

Clyde E. Markowitz

Neurology Reports

Switching Therapies in MS: What Are the Options?

Clyde E. Markowitz, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keywords: medical conditions, None, None, None

Breakthrough disease is common, even in patients with good adherence to their medications. Read this Neurology Report to learn ways to assess and manage adherence, monitor disease course through clinical and MRI measures, and make timely treatment adjustments in your patients with multiple sclerosis.

Clyde E. Markowitz

Neurology Reports

Identifying and Addressing Unmet Therapeutic Needs in MS

Clyde E. Markowitz, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keywords: medical conditions, None, None, None

Current disease-modifying treatments in multiple sclerosis (MS) are effectively mainly in relapsing forms of MS and do not restore function. Read this Neurology Report to discover unmet needs for treatments of progressive MS and MS symptoms and to learn about the development of neuroprotective agents.

Harold Moses, Jr

Neurology Reports

Recognizing and Overcoming Potential Barriers to Oral Medications for MS

Harold Moses, Jr, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keywords: medical conditions, None, None, None

New! Learn about the positive and negative aspects of the 3 FDA-approved oral medications for MS including their associated risks and benefits.

Harold Moses, Jr

Neurology Reports

Current Standards of Treatment in MS and the Role of Oral Agents

Harold Moses, Jr, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2017 | Keywords: medical conditions, None, None, None

New! In this Neurology Report, learn about the efficacy and safety profiles of current MS treatments. Plus, weigh the advantages and disadvantages associated with oral medications.

+Improving Depression Outcomes by Providing Safe and Effective Care in the Rural Setting [Series Home Page]

J. Sloan Manning and W. Clay Jackson

Psychlopedia

Treating Depression in Primary Care: Initial and Follow-Up Treatment Strategies

J. Sloan Manning, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: depression, None, None, None

What follow-up strategies do you use to help your patients with depression who don’t respond adequately to initial treatment? Here, get guidance on how to choose appropriate first-line treatment, and learn how to monitor patients and make timely treatment adjustments.

J. Sloan Manning and W. Clay Jackson

Psychlopedia

Providing Guideline-Concordant Assessment and Monitoring for Major Depression in Primary Care

J. Sloan Manning, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2017 | Keywords: depression, None, None, None

How do you screen patients for depression in a busy primary care setting? In this new activity, read about effective assessment tools and strategies to diagnose depression and how to set goals and monitor progress once patients begin treatment.

+Depression: Addressing Partial Response After First-Line Antidepressant Treatment [Series Home Page]

Thase et al

Journal CME

Depression: Addressing Partial Response After First-Line Antidepressant Treatment

Michael E. Thase, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2017 | Keywords: depression, None, None, None

How do you assess and treat residual symptoms in your patients who experience partial response to antidepressant therapy? Explore this Commentary to read a summary of 3 activities that provide assessment tools and treatment strategies for partial response and to learn areas of unmet needs and future education in depression treatment.

Andrew A. Nierenberg

Psychlopedia

Strategies for Achieving Full Remission When First-Line Antidepressants Are Not Enough

Andrew A. Nierenberg, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2016 | Keywords: depression, None, None, None

Discover how to assess problems with first-line treatment and implement the best second-line treatment option to help your patients achieve asympomatic remission.

Maurizio Fava

Psychlopedia

Assessing Response to Treatment and Recognizing Residual Depressive Symptoms

Maurizio Fava, MD

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2016 | Keywords: depression, None, None, None

New! Discover how to assess your patients' response to treatment and recognize residual symptoms so that you can implement appropriate next-step strategies.

Michael E. Thase

Psychlopedia

Residual Symptoms and the Risk of Relapse in Major Depression

Michael E. Thase, MD

Activity | Posttest | Credits: 0.50 | Expires: 8/31/2016 | Keywords: depression, None, None, None

Find out how residual symptoms increase your patients' risk for relapse and how to apply treatment options to help them achieve asymptomatic remission.

+Controversies in the Psychopharmacology of Bipolar Disorder [Series Home Page]

Robert M. Post, et al

Psychlopedia

Controversies in the Psychopharmacology of Bipolar Disorder

Robert M. Post, MD (Chair), et al

Activity | Posttest | Credits: 1.00 | Expires: 8/31/2017 | Keywords: bipolar disorder, None, None, None

What decision-making process do you use for selecting treatment for your patients with bipolar disorder? In this activity, review pharmacologic principles for the use of mood stabilizers, antipsychotics, and antidepressants, and find out how to choose appropriate therapies for maintenance treatment and partial response.

+Poster Sessions From The 2014 ASCP Annual Meeting [Series Home Page]

+Appropriate Management of Multiple Sclerosis in Primary Care [Series Home Page]

Levin and Jackson

Neurology Reports

Developing a Therapeutic Plan for MS: Evidence for New Treatments

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2017 | Keywords: medical conditions, None, None, None

Do you tailor your treatment plan for patients with MS according to their disease course and preferred administration method? Read this new Neurology Report to review the benefits and adverse effects of the available disease-modifying agents for MS and to select appropriate relapse treatment.

Levin and Jackson

Neurology Reports

Diagnosing MS: Recognizing Common Symptoms and Interpreting MRI Results

Michael C. Levin, MD, and W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2017 | Keywords: medical conditions, None, None, None

Early diagnosis of MS is critical for patients to begin disease-modifying therapy as soon as possible. Read this new Neurology Report to learn how to apply updated diagnostic criteria to recognize MS in its early stages and to rule out conditions similar to MS using appropriate tests.

+Update on Best Practices for Managing Bipolar Depression [Series Home Page]

Gary S. Sachs and Terence A. Ketter

Journal CME

Update on Best Practices for Managing Bipolar Depression

Gary S. Sachs, MD, and Terence A. Ketter, MD

Activity | Posttest | Credits: 1.00 | Expires: 5/31/2017 | Keywords: bipolar depression, bipolar disorder, None, None

New! This Commentary summarizes 2 CME activities on managing bipolar depression through using measurement-based assessments and knowing which medications are most effective.

+Measurement-Based Strategies to Assess and Manage Schizophrenia    [Series Home Page]

Leslie Citrome

Psychlopedia

New Treatment Targets to Improve Symptoms in Schizophrenia

Leslie Citrome, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

A paradigm shift in schizophrenia treatment is focusing on the glutamate system for new agents to address all symptom domains. Read this new Psychlopedia activity to learn what adjunctive agents are in development to treat negative and cognitive symptoms as well as agents that work through different pathways.

Philip D. Harvey

Psychlopedia

Assessing Disability in Schizophrenia: Tools and Contributors

Philip D. Harvey, PhD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

How do you measure everyday functioning in your patients with schizophrenia? Read this Psychlopedia activity to learn about strategies and tools to assess your patients' functional disability and to discover factors that contribute to functional disability so you can select appropriate interventions.

Stefan Leucht, MD

Psychlopedia

Measuring Outcomes in Schizophrenia and Examining Their Clinical Application

Stefan Leucht, MD

Activity | Posttest | Credits: 0.50 | Expires: 3/31/2017 | Keywords: schizophrenia, None, None, None

Different definitions for patient outcomes can make study results difficult to compare and apply to your patients' treatment. Read this new Psychlopedia activity to understand criteria for response, remission, and recovery and how to apply study results to your own patients' treatment plans and goals.

Brian Kirkpatrick

Psychlopedia

Recognizing Primary Vs Secondary Negative Symptoms and Apathy Vs Expression Domains

Brian Kirkpatrick, MD, MSPH

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: schizophrenia, None, None, None

Your patients' negative symptoms could be caused by depression, psychotic symptoms, medication side effects, or substance abuse. Read this new Psychlopedia activity to learn how to differentiate and treat the cause of negative symptoms and to recognize symptoms of apathy and diminished expression that emerge in most factor analysis studies of rating scales.

Leslie Citrome et al

Journal Supplement

Measurement-Based Strategies to Assess and Manage Schizophrenia

Leslie Citrome, MD, MPH (Chair), et al

Activity | Posttest | Credits: 3.00 | Expires: 3/31/2017 | Keywords: schizophrenia, None, None, None

Persisting negative and cognitive symptoms negatively impact patients' functioning, quality of life, and chances for achieving recovery. In this Supplement, learn how to disinguish between primary and secondary negative symptoms, find out how to assess your patients' treatment response and functioning, and discover new therapeutic targets in the treatment of schizophrenia to comprehensively address all presentations of the disorder.

+Benefits and Barriers to Using Long-Acting Injectable Antipsychotics in Schizophrenia [Series Home Page]

Christoph U. Correll

Psychlopedia

The Role of the Extended Health Care Team in Successful LAI Therapy: Education to Overcome Barriers

Christoph U. Correll, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

Learn about the pros and cons of LAI antipsychotics and ways to address health care team concerns.

Christoph U. Correll

Psychlopedia

Recognition of Patients Who Would Benefit From LAI Antipsychotic Treatment: How to Assess Adherence

Christoph U. Correll, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

What methods do you use to assess your patients' medication adherence? Read this Psychlopedia activity to realize the factors that contribute to adherence problems and to discover multiple methods to assess adherence as well as how to identify patients who would benefit from long-acting injectable antipsychotic treatment.

John M. Kane

Psychlopedia

Attitudinal Barriers to Prescribing LAI Antipsychotics in the Outpatient Setting: Communicating With Patients, Families, and Caregivers

John M. Kane, MD

Activity | Posttest | Credits: 0.50 | Expires: 4/30/2017 | Keywords: schizophrenia, None, None, None

What concerns regarding long-acting injectable antipsychotic treatment do you have? Check out this activity to review common attitudes that keep some clinicians from using this treatment as well as how to recognize which patients would benefit the most from this option.

John M. Kane

Psychlopedia

Organizational Barriers to Using Long-Acting Injectable Antipsychotics in Practice

John M. Kane, MD

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: schizophrenia, None, None, None

Despite evidence of their benefits, long-acting injectable antipsychotics are underused in the US. In this multimedia activity, learn ways to overcome common misconceptions and logistical problems that hinder the use of LAI antipsychotics. Plus, see how leadership and staff buy-in are crucial for implementing this treatment.

+Improving the Diagnosis and Management of Depression in Bipolar Disorder [Series Home Page]

Paul E. Keck

Psychlopedia

Monitoring Pharmacotherapy Response, Safety, and Tolerability to Enhance Adherence in Bipolar Disorder

Paul E. Keck, Jr., MD

Activity | Posttest | Credits: 0.50 | Expires: 3/31/2017 | Keywords: bipolar disorder, None, None, None

New! Learn how to use rating scales to track efficacy and discover ways to monitor common side effects.

Terence A. Ketter

Psychlopedia

Acute and Maintenance Treatment for Bipolar Depression

Terence A. Ketter, MD

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: bipolar depression, bipolar disorder, None, None

Depression in bipolar disorder can be difficult to diagnose and challenging to treat. Learn how to select evidence-based treatment and help your patients with bipolar depression achieve and maintain remission.

Eduard Vieta

Psychlopedia

Emerging Trends: Novel Molecular Targets and Moving Beyond Acute Symptoms in Bipolar Depression

Eduard Vieta, PhD

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: bipolar disorder, None, None, None

Are you up on the latest research for bipolar depression treatments? Here, review existing medications and find out about new treatments, like glutamatergic modulators, dopamine agonists, psychostimulants, and other agents, to help your patients with bipolar depression achieve remission while having a low side-effect burden.

Roger S. McIntyre

Psychlopedia

Improving the Early Recognition and Diagnosis of Bipolar Disorder

Roger S. McIntyre, MD, FRCPC

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2016 | Keywords: bipolar depression, bipolar disorder, None, None

Find out how to use DSM criteria to screen for bipolar disorder and to recognize other features that indicate this illness.

+Improving the Differential Diagnosis and Treatment of Bipolar Depression in Primary Care [Series Home Page]

Susan L. McElroy

Psychlopedia

Prescribing Antidepressants for Bipolar Depression: What Does the Evidence Say?

Susan L. McElroy, MD

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: bipolar depression, None, None, None

Antidepressants continue to be prescribed as monotherapy to patients with bipolar depression even though guidelines advise against them. Here, Dr McElroy summarizes why antidepressant monotherapy is not recommended by current guidelines, what risks are associated with their use, and when their use is indicated.

Susan L. McElroy, MD

Psychlopedia

Pros and Cons of Approved Therapies for Bipolar Depression and Ongoing Unmet Needs

Susan L. McElroy, MD

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: bipolar depression, None, None, None

Only 3 medications are currently FDA-approved for the treatment of bipolar depression. Read this new Psychlopedia to learn the effectiveness and adverse effects of approved bipolar depression treatments and to discover areas for future study.

Larry Culpepper

Psychlopedia

Differential Diagnosis of Unipolar Vs Bipolar Depression

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 2/28/2017 | Keywords: bipolar depression, bipolar disorder, None, None

New! Read about 2 effective tools for screening for bipolar disorder and how to use them throughout treatment to recognize red flags that indicate this illness.

Larry Culpepper, MD, MPH

Psychlopedia

Misdiagnosis of Bipolar Depression in Primary Care Practices

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 11/30/2016 | Keywords: bipolar depression, None, None, None

About one-third of patients with bipolar disorder wait 10 or more years before receiving a correct diagnosis. Read this new Psychlopedia activity to learn how to provide an accurate and timely diagnosis for your patients with bipolar disorder by differentiating unipolar and bipolar depression and assessing patients for manic and hypomanic episodes.

+Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies [Series Home Page]

Michael E. Thase

Psychlopedia

Update on Treatment-Resistant Depression: Translating Clinical Science Into Effective Therapies

Michael E. Thase, MD

Activity | Posttest | Credits: 1.00 | Expires: 1/31/2017 | Keywords: depression, None, None, None

How do you know if your patients are treatment resistant? In this activity, find out how to categorize treatment-resistant depression, what the risk factors are, and how to recognize and treat it to improve overall outcomes.

+Restless Legs Syndrome: Recognition, Diagnosis, and Treatment of a Common Sleep Disorder [Series Home Page]

Christopher J. Earley

Neurology Reports

Latest Guidelines and Advances for Treatment of Restless Legs Syndrome

Christopher J. Earley, MBBCh, PhD, FRCPI

Activity | Posttest | Credits: 0.50 | Expires: 1/31/2017 | Keywords: sleep disorders, pain, None, None

Which agents are best for which patients with restless legs syndrome? Find out about treatment options to relieve your patients' disturbed sleep and painful symptoms.

William G. Ondo

Neurology Reports

Common Comorbidities and Differential Diagnosis of Restless Legs Syndrome

William G. Ondo, MD

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2016 | Keywords: medical conditions, sleep disorders, None, None

New! Discover which disorders are often confused with restless legs syndrome (RLS) and which conditions and medications are associated with secondary RLS.

Richard P. Allen

Neurology Reports

Screening for Sleep Disorders: Recognizing the Features and Presentations of Restless Legs Syndrome

Richard P. Allen, PhD

Activity | Posttest | Credits: 0.50 | Expires: 12/31/2016 | Keywords: medical conditions, sleep disorders, None, None

New! Learn how misconceptions about restless legs syndrome can hinder its correct diagnosis and discover how diagnostic criteria can improve your ability to identify this condition.

+Biological Therapies in Psychiatry [Series Home Page]

+Treatment of Depression in Primary Care: Using Tools to Improve Outcomes [Series Home Page]

Larry Culpepper and Madhukar H. Trivedi

PCC CME

Using Measurement-Based Care With Patient Involvement to Improve Outcomes in Depression

Larry Culpepper, MD, MPH, and Madhukar H. Trivedi, MD

Activity | Posttest | Credits: 1.00 | Expires: 11/30/2016 | Keywords: depression, atypical depression, medical conditions, None

New! This Commentary summarizes an online CME program on the treatment of depression and assesses outcomes of that program.

+Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission [Series Home Page]

Zajecka, MD et al

Journal Supplement

Depression: Managing the Full Range of Symptoms to Achieve Lasting Remission

John M. Zajecka, MD (Chair), et al

Activity | Posttest | Credits: 2.50 | Expires: 10/31/2016 | Keywords: depression, None, None, None

Do you treat your patients with MDD until they are asymptomatic? Read this CME Supplement to find out how to recognize, monitor, and treat residual symptoms.

+Working Together to Restore Mental Well-Being and Address Domestic Violence Among Veterans: A Call To Action [Series Home Page]

Casey T. Taft

Psychlopedia

Working Together to Address Domestic Violence Among Veterans

Casey T. Taft, PhD

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2016 | Keywords: PTSD, mental illness, None, None

Participate in this brief activity to get an overview of core themes in troubled relationships as well as ways to assess for, prevent, and address intimate partner violence in veterans and their families.

Dao et al

Journal CME

Preventing Domestic Violence in Families of Veterans

Jim Dao (moderator), et al

Activity | Posttest | Credits: 1.00 | Expires: 10/31/2016 | Keywords: PTSD, substance use disorders, mental illness, None

Review highlights from a discussion among experts regarding best practices for preventing and identifying violence in the families of veterans.

+Complicated OCD: Issues of Comorbidity and Clinical Challenges [Series Home Page]

Jennifer G. Wells

Psychlopedia

Obsessive-Compulsive Disorder in Youth: Assessment and Treatment

Jennifer G. Wells, MSW, LISW

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2016 | Keywords: anxiety, obsessive-compulsive disorder, None, None

Do you have young patients with OCD? Engage in this brief activity to understand how developmental factors, family involvement, and comorbidities affect treatment. Also, find out how to distinguish typical OCD from an infection-triggered illness in youth.

Charles F. Brady

Psychlopedia

Presentation and Treatment of Complicated Obsessive-Compulsive Disorder

Charles F. Brady, PhD, ABPP

Activity | Posttest | Credits: 0.50 | Expires: 10/31/2016 | Keywords: anxiety, obsessive-compulsive disorder, None, None

Do you have patients with OCD whose obsessions are of suicide or whose compulsions are dangerous? Get practical tips on addressing these issues.

Charles F. Brady

Psychlopedia

Obsessive-Compulsive Disorder and Common Comorbidities

Charles F. Brady, PhD, ABPP

Activity | Posttest | Credits: 0.50 | Expires: 9/30/2016 | Keywords: anxiety, obsessive-compulsive disorder, depression, eating disorders

New! Find out about adjustments in both psychotherapy and pharmacotherapy for patients with OCD and comorbid depression, bipolar disorder, schizophrenia, or eating disorders.

+Understanding the Sleep-Wake Cycle: Sleep, Insomnia, and the Orexin System [Series Home Page]

+Assessing and Managing Pain and Major Depression With Medical Comorbidities [Series Home Page]

W. Clay Jackson

VS - Virtual Slide Set

Assessing and Managing Pain and Major Depression With Medical Comorbidities

W. Clay Jackson, MD, DipTh

Activity | Posttest | Credits: 1.00 | Expires: 9/30/2016 | Keywords: depression, pain, medical conditions, None

Watch this multimedia slide show to learn about the co-occurrence of pain, depression, and medical comorbidities.

+NCDEU Poster Session 2013 [Series Home Page]

+Schizophrenia: Using Long-Acting Injectable Antipsychotics to Improve Treatment Adherence [Series Home Page]

Stephen R. Marder

Psychlopedia

Monitoring Treatment and Managing Adherence in Schizophrenia

Stephen R. Marder, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2016 | Keywords: schizophrenia, None, None, None

Review ways to assess and address barriers to adherence and to monitor side effects that contribute to nonadherence and dangerous health conditions.

John M. Kane

Psychlopedia

Improving Patient Outcomes in Schizophrenia: Achieving Remission, Preventing Relapse, and Measuring Success

John M. Kane, MD

Activity | Posttest | Credits: 0.50 | Expires: 7/31/2016 | Keywords: schizophrenia, None, None, None

Get an overview of how to apply treatment goals to improve your patients' adherence and increase the proportion who reach recovery.

Christoph U. Correll

Psychlopedia

Addressing Barriers to Using Long-Acting Injectable Antipsychotics and Appropriately Monitoring Antipsychotic Adverse Effects

Christoph U. Correll, MD

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2016 | Keywords: schizophrenia, None, None, None

See how study design affects the results of LAI efficacy in schizophrenia, how to overcome barriers to using LAI treatment, and how to monitor common side effects associated with antipsychotics.

+The Effects of the Affordable Care Act on the Practice of Psychiatry [Series Home Page]

Ebert et al

Psychlopedia

The Affordable Care Act and Practice in Psychiatry

Michael H. Ebert, MD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 6/30/2016 | Keywords: mental illness, None, None, None

Find out how the Affordable Care Act will affect the care of patients with mental health disorders, practitioners, and future research.

+ADHD in College, Phase II: Managing the Risk of Misuse, Abuse, and Diversion [Series Home Page]

J. Sloan Manning

Psychlopedia

Strategies for Managing the Risks Associated With ADHD Medications

J. Sloan Manning, MD

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2016 | Keywords: ADHD, None, None, None

Find out how DSM criteria and rating scales can help you diagnose ADHD and screen for common comorbid conditions, and learn ways to reduce nonmedical use of your patients' prescriptions.

Larry Culpepper

Psychlopedia

Recognizing and Addressing Barriers to the Effective Management of ADHD in College Students

Larry Culpepper, MD, MPH

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2016 | Keywords: ADHD, None, None, None

Review the unique barriers to the diagnosis and management of ADHD in college students, and find out how to recognize those at risk for misusing their medication.

+Caring for Returning Veterans: Meeting Mental Health Needs [Series Home Page]

Keane et al

Psychlopedia

Mental Health Needs of Returning Veterans

Terence M. Keane, PhD (Chair), et al

Activity | Posttest | Credits: 0.50 | Expires: 5/31/2016 | Keywords: mental illness, PTSD, None, None

Find out what challenges veterans face in receiving mental health care, what you can do to better understand these patients, and what resources are available to help you meet their needs.

+Alzheimer's Disease: The Importance of Early Diagnosis and Appropriate Management [Series Home Page]

+Military- and Sports-Related Mild Traumatic Brain Injury: Clinical Presentation, Management, and Long-Term Consequences [Series Home Page]

+Expired Other [Series Home Page]

+Negative Symptoms in Schizophrenia: Treatment Gaps and Unmet Needs [Series Home Page]

+The Effect of Marijuana Use on the Risk for Schizophrenia [Series Home Page]

+Depression, Pain, and Comorbid Medical Conditions [Series Home Page]

+Improving Outcomes in Multiple Sclerosis Through Early Diagnosis and Effective Management [Series Home Page]

+A Fresh Look at Monoamine Oxidase Inhibitors for Depression [Series Home Page]

+NCDEU Poster Session 2012 [Series Home Page]

+The Appropriate Use of Opiates in Chronic Pain [Series Home Page]

+Multiple Sclerosis Syndromes and Symptoms: A Clinical Primer [Series Home Page]

+New Treatment Approaches for Major Depressive Disorder   [Series Home Page]

+Bipolar Disorder: Lessons for Rural Physicians: Adjunctive Interventions for Maintaining Remission [Series Home Page]

+Schizophrenia: When First-Line Treatment Fails [Series Home Page]

+ADHD in College: Seeking and Receiving Care During the Transition From Child to Adult [Series Home Page]

+Diagnosing and Managing Patients With Dementia [Series Home Page]

+Overview of Current Issues in the Management of Multiple Sclerosis [Series Home Page]

+International Consensus Group on Depression Prevention in Bipolar Disorder [Series Home Page]

+Alzheimer's Disease: Implications of the Updated Diagnostic and Research Criteria [Series Home Page]

+Fibromyalgia: Creating a Patient-Centered Diagnostic and Therapeutic Roadmap [Series Home Page]

+NCDEU Poster Session 2011 [Series Home Page]

+2011 ICBD Conference Coverage: Practical Applications of New Research in Bipolar Disorder [Series Home Page]

+Evidence for Using L-Methylfolate Combined With Antidepressants in MDD [Series Home Page]

+Depression: When Initial Therapy Fails [Series Home Page]

+Using Diagnostic and Assessment Tools for Adolescents With ADHD [Series Home Page]

+Using Moderator-Based Algorithms  and Electronic Medical Records  to Achieve Optimal Outcomes in Depression [Series Home Page]

+Expired Performance Improvement CME [Series Home Page]

+The Current Crisis of Confidence in Antidepressants [Series Home Page]

+New Approaches to Managing Schizoaffective Disorder From Diagnosis to Treatment [Series Home Page]

+NCDEU Poster Session 2010 [Series Home Page]

+Looking Past First-Line Therapy for Major Depressive Disorder [Series Home Page]

+Considerations in Managing Schizophrenia in Adolescents [Series Home Page]

+Challenges in the Long-Term Treatment of Schizophrenia [Series Home Page]

+Self-Assessment [Series Home Page]

+Improving Outcomes in Bipolar Disorder: From Early Recognition and Treatment to Remission [Series Home Page]

+Strategies for Selecting Treatment and Mitigating Risk in Patients With Chronic Pain [Series Home Page]

+Strategies for the Long-Term Treatment of Bipolar Disorder in Children and Adults [Series Home Page]

+Improving the Recognition and Treatment of Bipolar Disorder in Primary Care [Series Home Page]

+Improving Executive Function in Adults With ADHD [Series Home Page]

+Improving Outcomes in Depression [Series Home Page]

+International Consensus Group on Depression [Series Home Page]

+Debates and Directions in Fibromyalgia: Recognizing Signs and Selecting the Appropriate Paths [Series Home Page]

+Tackling Partial Remission to Depression Treatment [Series Home Page]

+The Use of Complementary and Alternative Medicines to Achieve Remission in Major Depressive Disorder [Series Home Page]

+NCDEU Poster Session 2009 [Series Home Page]

+What Is Bipolar Disorder? [Series Home Page]

+An Introduction to the Clinical Correlates of Disrupted Slow-Wave Sleep [Series Home Page]

+Following Up on The Expert Consensus Guidelines for Geriatric Depression [Series Home Page]

+Depression in Latinos: A Focus on Overcoming Barriers [Series Home Page]

+Bipolar Disorder in Children and Adolescents [Series Home Page]

+Definition and Management of Suicidality in Psychiatric Patients [Series Home Page]

+Balancing the Equation: Managing Medical Comorbidities in Patients With Severe Mental Illness [Series Home Page]

+Expired Case & Comment [Series Home Page]

+Maintenance of Certification in Psychiatry [Series Home Page]

+Bipolar Depression [Series Home Page]

+What Is Depression? [Series Home Page]

+Pain and the Brain 2: The Recognition and Management of Chronic Pain in Primary Care [Series Home Page]

+MDD in Women: Focus on Reproductive Events [Series Home Page]

+Using Atypical Antipsychotics to Optimize the Clinical Management of Patients With Mental Illnesses [Series Home Page]

+Depression in the Elderly [Series Home Page]

+Insights Into Generalized Anxiety Disorder [Series Home Page]

+Preventing Clinical Deterioration in the Course of Schizophrenia: The Potential for Neuroprotection [Series Home Page]

+ADHD and Comorbid Disorders in Adults [Series Home Page]

+Major Depressive Disorder [Series Home Page]

+Easing the Burden of Treatment-Resistant Depression [Series Home Page]

+Conference Coverage: 21st Annual European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

+Depression and Pain [Series Home Page]

+Depression, Pain, and Physical Symptoms [Series Home Page]

+Easing the Burden of Bipolar Disorder: From Urgent Situations to Remission [Series Home Page]

+Poster Session: NCDEU 2008 [Series Home Page]

+Understanding Fibromyalgia and Its Related Disorders [Series Home Page]

+Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap [Series Home Page]

+Clinical Insights Into Pharmacogenetics and Schizophrenia [Series Home Page]

+Pain and the Brain [Series Home Page]

+The Use of Atypical Antipsychotics in Pediatric Psychiatric Disorders [Series Home Page]

+Influencers of Treatment Success in Schizophrenia and Bipolar Disorder [Series Home Page]

+Maximizing Efficacy of Antidepressants Beyond Selective Serotonin Reuptake Inhibitors [Series Home Page]

+Conference Coverage: 20th European College of Neuropsychopharmacology (ECNP) Congress [Series Home Page]

+Smoking Cessation in Patients With Psychiatric Disorders [Series Home Page]

+A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia [Series Home Page]

+Raising the Bar in Schizophrenia by Treating to Remission [Series Home Page]

+Diagnosis and Treatment Strategies for Mixed Episodes in Bipolar Disorder [Series Home Page]

+Presentations From the Seventh International Conference on Bipolar Disorder [Series Home Page]

+Narcolepsy and Excessive Daytime Sleepiness: From the Bench to the Bedside [Series Home Page]

+Atypical Depression: Management Challenges and New Treatment Advances [Series Home Page]

+Cognitive Impairment Associated With Depression in the Elderly [Series Home Page]

+Managing Bipolar Disorder From Urgent Situations to Maintenance Therapy [Series Home Page]

+Weighing the Evidence: Weight Management Insights for Treating Major Mental Illness [Series Home Page]

+ADHD and Comorbid Substance Use Disorder [Series Home Page]

+Mixed Depression in Bipolar Disorders: Diagnosis and Treatment Strategies [Series Home Page]

+The Role of Folate in Depression and Dementia [Series Home Page]

+Strategies to Integrate Physical Health Care Into Mental Health [Series Home Page]

+Poster Session: NCDEU 2007 [Series Home Page]

+Special Issues Related to the Management of Bipolar Disorder in Women: Tolerability of Treatment [Series Home Page]

+Translating Evidence on Depression and Physical Symptoms into Effective Clinical Practice [Series Home Page]

+Distance Rounds [Series Home Page]

+Monoamine Oxidase Inhibitors Revisited: Their Role in Depressive Disorders [Series Home Page]

+The Art and Science of Switching Antipsychotic Medications [Series Home Page]

+Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness [Series Home Page]

+Preventing Recurrent Depression: Long-Term Treatment for Major Depressive Disorder [Series Home Page]

+Understanding Neuronal Pathways: Novel Targets for the Management of Insomnia [Series Home Page]

+Exercise for Mood and Anxiety Disorders [Series Home Page]

+Managing ADHD in Children, Adolescents, and Adults With Comorbid Anxiety [Series Home Page]

+Impact of Bipolar Disorder: Results From a Screening Study [Series Home Page]

+Transcranial Magnetic Stimulation: Potential New Treatment for Resistant Depression [Series Home Page]

+Evaluating the Evidence: Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and Beyond [Series Home Page]

+Practical Applications of Recent Antipsychotic Effectiveness Data [Series Home Page]

+Pathological Gambling: A Review of Phenomenological Models and Treatment Modalities for an Underrecognized Psychiatric Disorder [Series Home Page]

+ADHD: Applying Practice Guidelines to Improve Patient Outcome and Executive Function [Series Home Page]

+Practical Pharmacotherapeutic Management Strategies for Patients With Alcohol Dependence [Series Home Page]

+The Evolving View on Delta Sleep and Its Relationship to Daytime Function: A CME-Certified Virtual Symposium [Series Home Page]

+New Developments in Addiction Treatment [Series Home Page]

+Psychiatry in Brief: Insomnia and Emerging Therapies: Treating the Whole Patient [Series Home Page]

+Improving Cognitive Function and Functional Outcome in Severe Mental Illness [Series Home Page]

+Social Anxiety Disorder: Diagnosis, Outcome, Mechanisms, and Management [Series Home Page]

+Recent Advances in the Treatment of Depression in the Presence of Physical Symptoms [Series Home Page]

+Managing Patients With Vascular Disease and Depression [Series Home Page]

+Use of Treatment Algorithms for Depression [Series Home Page]

+Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD): A Clinical View [Series Home Page]

+New Developments in the Treatment of Attention-Deficit/Hyperactivity Disorder [Series Home Page]

+Bipolar Reports [Series Home Page]

+Antecedents to Panic Disorder in Nonreferred Adults [Series Home Page]

+The Challenges of Dual Diagnosis: Managing Substance Abuse in Severe Mental Illness [Series Home Page]

+A Systematic Review of Assessment and Treatment of Moderate to Severe Alzheimer's Disease [Series Home Page]

+Emerging Therapies for Bipolar Depression [Series Home Page]

+The Role of Dopamine and Norepinephrine in Depression and Antidepressant Treatment [Series Home Page]

+Agitated "Unipolar" Major Depression: Prevalence, Phenomenology, and Outcome [Series Home Page]

+Managing Nonadherence in Schizophrenia: The Role of Long-Acting Agents [Series Home Page]

+Distance Rounds [Series Home Page]

+Identifying and Managing Depression in the Medical Patient [Series Home Page]

+Atypical Antipsychotics in the Treatment of Mania: A Meta-Analysis of Randomized, Placebo-Controlled Trials [Series Home Page]

+Review of the Pharmacologic Management of Depression [Series Home Page]

+The Alzheimer's Disease Continuum: From Neuropathology to Clinical Practice [Series Home Page]

+The Impact of Disasters and Their Aftermath on Mental Health [Series Home Page]

+After the Tsunami: Mental Health Challenges to the Community for Today and Tomorrow [Series Home Page]

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

+The Recognition and Management of Bipolar Disorder With Comorbid Anxiety [Series Home Page]

+Focus on Bipolar Disorder Treatment [Series Home Page]

+Management of Autism and Its Related Disorders [Series Home Page]

+Sleep: New Frontiers in Psychiatry and Primary Care [Series Home Page]

+New Therapies for Treatment-Resistant Depression and Anxiety [Series Home Page]

+Safety Issues With Drug Therapies for Autism Spectrum Disorders [Series Home Page]

+Poster Session: July 2005 [Series Home Page]

+New Insights Into the Nature and Treatment of Panic Disorder [Series Home Page]

+The Role of Atypical Antipsychotics in the Treatment of Bipolar Disorder [Series Home Page]

+Utilizing Benzodiazepines in Clinical Practice: An Evidence-Based Discussion [Series Home Page]

+New Perspectives in Treating Bipolar Disorder [Series Home Page]

+The Need for Better Management of Treatment-Resistant Depression [Series Home Page]

+Differential Diagnosis and Management of Daytime Sleepiness and Nighttime Wakefulness [Series Home Page]

+Beyond Refractory Obsessions and Anxiety States: Toward Remission [Series Home Page]

+New Perspectives for Treating Generalized Anxiety Disorder [Series Home Page]

+Recognizing the Physical Symptoms of Depression [Series Home Page]

+Clinical Effectiveness of Atypical Antipsychotics in Dementia [Series Home Page]

+Managing Bipolar Depression [Series Home Page]

+Drug-Induced Movement Disorders [Series Home Page]

+Using Atypical Antipsychotics in Primary Care [Series Home Page]

+Revisiting the Use of High-Potency Benzodiazepines [Series Home Page]

+Diagnosing and Treating Attention-Deficit/Hyperactivity Disorder in Adults [Series Home Page]

+New Treatments for Depression Characterized by Physical Symptoms [Series Home Page]

+The Expert Consensus Guideline Series: Using Antipsychotic Agents in Older Patients [Series Home Page]

+Treating Aggressive Behavior in the Elderly [Series Home Page]

+Treating Depression: New Choices for a Chronic Problem [Series Home Page]

+Partial Compliance: The Need for Long-Acting Atypical Antipsychotics [Series Home Page]

+Optimizing Wakefulness in Patients With Fatigue and Executive Dysfunction [Series Home Page]

+The Expert Consensus Guideline Series: Optimizing Pharmacologic Treatment of Psychotic Disorders [Series Home Page]

+Long-Term Safety of Methylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse [Series Home Page]

+Noncholinergic Treatments for Alzheimer’s Disease [Series Home Page]

+Using the Newer Pharmacotherapeutic Agents as Mood Stabilizers in Bipolar Spectrum Disorders [Series Home Page]

+Physical Symptoms of Depression and Their Impact on Patients and Society [Series Home Page]

+Achieving Success in the Management of Bipolar Disorder: Is Lithium Sufficient? [Series Home Page]

+Management of Aggression Across the Life Cycle [Series Home Page]

+The Role of GABA in Neuropsychiatric Disorders: A Review of GABA Agents [Series Home Page]

+Treating Depression and Anxiety to Remission: Use of Algorithms [Series Home Page]

+New Approaches to Managing Difficult-to-Treat Depressions [Series Home Page]

+Anxiety: New Treatment Perspectives [Series Home Page]

CME Activities From Our Journals